Výsledky vyhledávání - Sebag, Michael
- Zobrazuji výsledky 1 - 17 z 17
-
1
-
2
-
3
Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma Autor Robert, Francis, Roman, William, Bramoullé, Alexandre, Fellmann, Christof, Roulston, Anne, Shustik, Chaim, Porco, John A., Shore, Gordon C., Sebag, Michael, Pelletier, Jerry
Vydáno 2014Text -
4
Oxo-aglaiastatin-Mediated Inhibition of Translation Initiation Autor Itoua Maïga, Rayelle, Cencic, Regina, Chu, Jennifer, Waller, Daniel D., Brown, Lauren E., Devine, William G., Zhang, Wenhan, Sebag, Michael, Porco Jr., John A., Pelletier, Jerry
Vydáno 2019Text -
5
Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity Autor Tiedemann, Rodger E., Mao, Xinliang, Shi, Chang-Xin, Zhu, Yuan Xiao, Palmer, Stephen E., Sebag, Michael, Marler, Ron, Chesi, Marta, Fonseca, Rafael, Bergsagel, P. Leif, Schimmer, Aaron D., Stewart, A. Keith
Vydáno 2008Text -
6
Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression Autor Croucher, Danielle C., Richards, Laura M., Tsofack, Serges P., Waller, Daniel, Li, Zhihua, Wei, Ellen Nong, Huang, Xian Fang, Chesi, Marta, Bergsagel, P. Leif, Sebag, Michael, Pugh, Trevor J., Trudel, Suzanne
Vydáno 2021Text -
7
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies Autor Chesi, Marta, Robbiani, Davide F., Sebag, Michael, Chng, Wee Joo, Affer, Maurizio, Tiedemann, Rodger, Valdez, Riccardo, Palmer, Stephen E., Haas, Stephanie S., Stewart, A. Keith, Fonseca, Rafael, Kremer, Richard, Cattoretti, Giorgio, Bergsagel, P. Leif
Vydáno 2008Text -
8
Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma Autor Bahlis, Nizar J., Sutherland, Heather, White, Darrell, Sebag, Michael, Lentzsch, Suzanne, Kotb, Rami, Venner, Christopher P., Gasparetto, Cristina, Del Col, Aldo, Neri, Paola, Reece, Donna, Kauffman, Michael, Shacham, Sharon, Unger, T. J., Jeha, Jacqueline, Saint-Martin, Jean-Richard, Shah, Jatin, Chen, Christine
Vydáno 2018Text -
9
Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure Autor Siegel, David S., Schiller, Gary J., Song, Kevin W., Agajanian, Richy, Stockerl‐Goldstein, Keith, Kaya, Hakan, Sebag, Michael, Samaras, Christy, Malek, Ehsan, Talamo, Giampaolo, Seet, Christopher S., Mouro, Jorge, Pierceall, William E., Zafar, Faiza, Chung, Weiyuan, Srinivasan, Shankar, Agarwal, Amit, Bahlis, Nizar J.
Vydáno 2019Text -
10
Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database Autor McCurdy, Arleigh, Venner, Christopher P., Masih-Khan, Esther, Louzada, Martha, LeBlanc, Richard, Sebag, Michael, Song, Kevin, Jimenez-Zepeda, Victor H., Kotb, Rami, Kardjadj, Moustafa, Mian, Hira, White, Darrell, Stakiw, Julie, Aslam, Muhammad, Reiman, Anthony, Gul, Engin, Reece, Donna
Vydáno 2022Text -
11
The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database Autor Cherniawsky, Hannah M., Kukreti, Vishal, Reece, Donna, Masih-Khan, Esther, McCurdy, Arleigh, Jimenez-Zepeda, Victor H., Sebag, Michael, Song, Kevin, White, Darrell, Stakiw, Julie, LeBlanc, Richard, Reiman, Anthony, Aslam, Muhammad, Louzada, Martha, Kotb, Rami, Gul, Engin, Atenafu, Eshetu, Venner, Christopher P.
Vydáno 2020Text -
12
Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment Autor Siegel, David S., Schiller, Gary J., Samaras, Christy, Sebag, Michael, Berdeja, Jesus, Ganguly, Siddhartha, Matous, Jeffrey, Song, Kevin, Seet, Christopher S., Talamo, Giampaolo, Acosta-Rivera, Mirelis, Bar, Michael, Quick, Donald, Anz, Bertrand, Fonseca, Gustavo, Reece, Donna, Pierceall, William E., Chung, Weiyuan, Zafar, Faiza, Agarwal, Amit, Bahlis, Nizar J.
Vydáno 2020Text -
13
Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis Autor Mian, Hira, Eisfeld, Christine, Venner, Christopher P., Masih-Khan, Esther, Kardjadj, Moustafa, Jimenez-Zepeda, Victor H., Khandanpour, Cyrus, Lenz, Georg, McCurdy, Arleigh, Sebag, Michael, Song, Kevin, LeBlanc, Richard, White, Darrell, Stakiw, Julie, Reiman, Anthony, Louzada, Martha, Aslam, Muhammad, Kotb, Rami, Gul, Engin, Reece, Donna
Vydáno 2022Text -
14
Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma Autor Gasparetto, Cristina, Lentzsch, Suzanne, Schiller, Gary, Callander, Natalie, Tuchman, Sascha, Chen, Christine, White, Darrell, Kotb, Rami, Sutherland, Heather, Sebag, Michael, Baljevic, Muhamed, Bensinger, William, LeBlanc, Richard, Venner, Chris, Bahlis, Nizar, Rossi, Adriana, Biran, Noa, Sheehan, Heidi, Saint‐Martin, Jean‐Richard, Van Domelen, Dane, Kai, Kazuharu, Shah, Jatin, Shacham, Sharon, Kauffman, Michael, Lipe, Brea
Vydáno 2020Text -
15
An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma Autor Vij, Ravi, Wang, Michael, Kaufman, Jonathan L., Lonial, Sagar, Jakubowiak, Andrzej J., Stewart, A. Keith, Kukreti, Vishal, Jagannath, Sundar, McDonagh, Kevin T., Alsina, Melissa, Bahlis, Nizar J., Reu, Frederic J., Gabrail, Nashat Y., Belch, Andrew, Matous, Jeffrey V., Lee, Peter, Rosen, Peter, Sebag, Michael, Vesole, David H., Kunkel, Lori A., Wear, Sandra M., Wong, Alvin F., Orlowski, Robert Z., Siegel, David S.
Vydáno 2012Text -
16
Promiscuous Mutations Activate the Non-Canonical NF-kB Pathway in Multiple Myeloma Autor Keats, Jonathan J., Fonseca, Rafael, Chesi, Marta, Schop, Roelandt, Baker, Angela, Chng, Wee-Joo, Van Wier, Scott, Tiedemann, Rodger, Shi, Chang-Xin, Sebag, Michael, Braggio, Esteban, Henry, Travis, Zhu, Yuan-Xiao, Fogle, Homer, Price-Troska, Tammy, Ahmann, Gregory, Mancini, Catherine, Brents, Leslie A., Kumar, Shaji, Greipp, Philip, Dispenzieri, Angela, Bryant, Barb, Mulligan, George, Bruhn, Laurakay, Barrett, Michael, Valdez, Riccardo, Trent, Jeff, Stewart, A. Keith, Carpten, John, Bergsagel, P. Leif
Vydáno 2007Text -
17
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients Autor Gasparetto, Cristina, Schiller, Gary J., Tuchman, Sascha A., Callander, Natalie S., Baljevic, Muhamed, Lentzsch, Suzanne, Rossi, Adriana C., Kotb, Rami, White, Darrell, Bahlis, Nizar J., Chen, Christine I., Sutherland, Heather J., Madan, Sumit, LeBlanc, Richard, Sebag, Michael, Venner, Christopher P., Bensinger, William I., Biran, Noa, Ammu, Sonia, Ben-Shahar, Osnat, DeCastro, Andrew, Van Domelen, Dane, Zhou, Tianjun, Zhang, Chris, Bentur, Ohad S., Shah, Jatin, Shacham, Sharon, Kauffman, Michael, Lipe, Brea
Vydáno 2021Text